{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:47:47Z","timestamp":1784238467483,"version":"3.55.0"},"reference-count":496,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Human pregnancy is a complex condition that poses significant challenges for women due to the necessity of a uterus for key processes such as fertilization, embryo implantation, fetal development, and childbirth. These processes are governed by immunological factors and accompanied by various physiological changes. For a successful pregnancy, maternal immune reprogramming is crucial because the developing embryo is considered a semi-allograft. Any immunological alteration during pregnancy induces recurrent pregnancy loss and other fetal\u2013maternal health issues, including preeclampsia. However, despite advances in reproductive immunology, the exact immunopathogenesis of preeclampsia remains unclear. The complement system (CS) is an evolutionarily ancient and critical innate immune component that plays a significant role in maintaining immune homeostasis. The current article discusses the critical role of the CS in human pregnancy and how its dysregulation predisposes pregnant women to preeclampsia. The article introduces the concept of the Th1 to Th2 immunological shift as a prerequisite for a successful pregnancy and the evolution of decidualization via transposable elements, which recruit genes responsible for the process in the endometrium. The immune system plays a critical role in decidualization. The second section discusses the CS signaling pathway, its negative regulators, and the roles of the C3a\/C3aR and C5a\/C5aR1\/C5aR2 or C5L2 axis in immune homeostasis. The third section elaborates on the role of the CS in the establishment of human pregnancy, such as fertilization, implantation, and fetal development. The fourth section describes maternal CS signaling alteration during successful human pregnancy. The fifth section describes the role of CS signaling in preeclampsia, including its systemic and local (placental) alterations and the responsible mechanisms. The article closes with future perspectives and a summary that describes important complement-based approaches for diagnosing and treating preeclampsia.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1617140","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T05:19:42Z","timestamp":1755580782000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["The complement system in human pregnancy and preeclampsia"],"prefix":"10.3389","volume":"16","author":[{"given":"Vijay","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"IV","given":"John H.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.22034\/iji.2008.48555","article-title":"Emerging role of uterine natural killer cells in establishing pregnancy","volume":"5","author":"Kumar","year":"2008","journal-title":"Iranian J Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-020-00362-7","article-title":"A pregnancy to remember: trained immunity of the uterine mucosae","volume":"14","author":"Feyaerts","year":"2021","journal-title":"Mucosal Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.it.2018.02.006","article-title":"Immunology of uterine and vaginal mucosae: (Trends in immunology 39, 302-314, 2018)","volume":"39","author":"Zhou","year":"2018","journal-title":"Trends Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpobgyn.2019.05.009","article-title":"Decidual immune cells: Guardians of human pregnancies","volume":"60","author":"Solano","year":"2019","journal-title":"Best Pract Res Clin Obstetrics Gynaecology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(93)90235-D","article-title":"Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon","volume":"14","author":"Wegmann","year":"1993","journal-title":"Immunol Today"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0378(96)00995-3","article-title":"Is there a Th2 bias in human pregnancy","volume":"32","author":"Vince","year":"1996","journal-title":"J Reprod Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-102119-075119","article-title":"Natural killer cells in the human uterine mucosa","volume":"41","author":"Male","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(98)01393-0","article-title":"An innate view of human pregnancy","volume":"20","author":"Sacks","year":"1999","journal-title":"Immunol Today"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2023.05.009","article-title":"Immunobiology of pregnancy: from basic science to translational medicine","volume":"29","author":"Colamatteo","year":"2023","journal-title":"Trends Mol Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpobgyn.2020.07.013","article-title":"Immunology and the immunological response in pregnancy","volume":"76","author":"Orefice","year":"2021","journal-title":"Best Pract Res Clin Obstetrics Gynaecology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nri3761","article-title":"Complement\u2013tapping into new sites and effector systems","volume":"14","author":"Kolev","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/08830185.2019.1609962","article-title":"The complement system, toll-like receptors and inflammasomes in host defense: three musketeers\u2019 one target","volume":"38","author":"Kumar","year":"2019","journal-title":"Int Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-006-0142-1","article-title":"Genomic view of the evolution of the complement system","volume":"58","author":"Nonaka","year":"2006","journal-title":"Immunogenetics"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.12.052","article-title":"Ancient transposable elements transformed the uterine regulatory landscape and transcriptome during the evolution of mammalian pregnancy","volume":"10","author":"Lynch","year":"2015","journal-title":"Cell Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00926-1","article-title":"A guide to complement biology, pathology and therapeutic opportunity","volume":"24","author":"Mastellos","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-022-00774-4","article-title":"Understanding the contextual functions of C1q and LAIR-1 and their applications","volume":"54","author":"Son","year":"2022","journal-title":"Exp Mol Med"},{"key":"B17","article-title":"The complement system in liver diseases","volume":"3","author":"Qin","year":"2006","journal-title":"Cell Mol Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30508","article-title":"The role of complement in liver injury, regeneration, and transplantation","volume":"70","author":"Thorgersen","year":"2019","journal-title":"Hepatology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12952","article-title":"Production of complement components by cells of the immune system","volume":"188","author":"Lubbers","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/0167-5699(90)90031-4","article-title":"Evolutionary implications of a new bypass activation pathway of the complement system","volume":"11","author":"Farries","year":"1990","journal-title":"Immunol Today"},{"key":"B21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0167-5699(91)90002-B","article-title":"Evolution of the complement system","volume":"12","author":"Farries","year":"1991","journal-title":"Immunol Today"},{"key":"B22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/imr.12500","article-title":"Complement component C3 - The \u201cSwiss Army Knife\u201d of innate immunity and host defense","volume":"274","author":"Ricklin","year":"2016","journal-title":"Immunol Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1403068","article-title":"Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth","volume":"194","author":"Coulthard","year":"2015","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/imr.13155","article-title":"Factor D","volume":"313","author":"Sekine","year":"2023","journal-title":"Immunol Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.712572","article-title":"Complement factor D as a strategic target for regulating the alternative complement pathway","volume":"12","author":"Barratt","year":"2021","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2008.00350.x","article-title":"The alternative complement pathway revisited","volume":"12","author":"Harboe","year":"2008","journal-title":"J Cell Mol Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.142.4.856","article-title":"Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase","volume":"142","author":"Fearon","year":"1975","journal-title":"J Exp Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"47s","DOI":"10.1111\/1523-1747.ep12275445","article-title":"The killer molecule of complement","volume":"85","author":"M\u00fcller-Eberhard","year":"1985","journal-title":"J Invest Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/0161-5890(84)90044-0","article-title":"Membrane attack by complement","volume":"21","author":"Podack","year":"1984","journal-title":"Mol Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0171-2985(98)80042-9","article-title":"3rd, Regulation of C1 inhibitor synthesis","volume":"199","author":"Prada","year":"1998","journal-title":"Immunobiology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106109","article-title":"Development of \u03b3G, \u03b3A, \u03b3M, \u03b2 1C\/\u03b2 1A, C\u2032 1 esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, \u03b1 1-antitrypsin, orosomucoid, \u03b2-lipoprotein, \u03b1 2-macroglobulin, and prealbumin in the human conceptus","volume":"48","author":"Gitlin","year":"1969","journal-title":"J Clin Invest"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111680","article-title":"Platelet C1- inhibitor. A secreted alpha-granule protein","volume":"75","author":"Schmaier","year":"1985","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.2.465.465","article-title":"Expression of platelet C1 inhibitor","volume":"82","author":"Schmaier","year":"1993","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.2.373","article-title":"C1 esterase inhibitor gene expression in rat Kupffer cells, peritoneal macrophages and blood monocytes: modulation by interferon gamma","volume":"178","author":"Armbrust","year":"1993","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.142.6.2041","article-title":"Synthesis and regulation of C1 inhibitor in human skin fibroblasts","volume":"142","author":"Katz","year":"1989","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1172\/JCI107967","article-title":"Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin","volume":"55","author":"Harpel","year":"1975","journal-title":"J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1006\/clin.1997.4515","article-title":"A newly discovered function for C1 inhibitor, removal of the entire C1qr2s2 complex from immobilized human IgG subclasses","volume":"87","author":"Chen","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1998.00635.x","article-title":"C1 inhibitor removes the entire C1qr2s2 complex from anti-C1Q monoclonal antibodies with low binding affinities","volume":"95","author":"Chen","year":"1998","journal-title":"Immunology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107313","article-title":"Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation","volume":"52","author":"Schreiber","year":"1973","journal-title":"J Clin Invest"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.2.315","article-title":"The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C\u20191r subcomponent of the first component of complement by serum C\u20191 esterase inhibitor","volume":"129","author":"Ratnoff","year":"1969","journal-title":"J Exp Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.11.1609","article-title":"Complement 1 inhibitor is a regulator of the alternative complement pathway","volume":"194","author":"Jiang","year":"2001","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.9.4786","article-title":"III, complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion 1","volume":"171","author":"Cai","year":"2003","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2005.02726.x","article-title":"C1 inhibitor deficiency: consensus document","volume":"139","author":"Gompels","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"152410","DOI":"10.1016\/j.imbio.2023.152410","article-title":"Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic","volume":"228","author":"Hallam","year":"2023","journal-title":"Immunobiology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2011.04.004","article-title":"Complement factor I in health and disease","volume":"48","author":"Nilsson","year":"2011","journal-title":"Mol Immunol"},{"key":"B47","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.82.3.859","article-title":"Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines","volume":"82","author":"Cole","year":"1985","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B48","doi-asserted-by":"publisher","first-page":"101341","DOI":"10.1016\/j.smim.2019.101341","article-title":"Regulation of regulators: Role of the complement factor H-related proteins","volume":"45","author":"Cserhalmi","year":"2019","journal-title":"Semin Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.immuni.2023.06.026","article-title":"Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis","volume":"56","author":"Kiss","year":"2023","journal-title":"Immunity"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018025692","article-title":"Potentiation of complement regulator factor H protects human endothelial cells from complement attack in aHUS sera","volume":"3","author":"Pouw","year":"2019","journal-title":"Blood Adv"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.033","article-title":"Local complement factor H protects kidney endothelial cell structure and function","volume":"100","author":"Mahajan","year":"2021","journal-title":"Kidney Int"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1755","article-title":"Structure of complement fragment C3b\u2013factor H and implications for host protection by complement regulators","volume":"10","author":"Wu","year":"2009","journal-title":"Nat Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1368852","article-title":"Complement-Coagulation Cross-talk: Factor H-mediated regulation of the Complement Classical Pathway activation by fibrin clots","volume":"15","author":"Kang","year":"2024","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2021.05.015","article-title":"Beyond factor H: The impact of genetic-risk variants for age-related macular degeneration on circulating factor-H-like 1 and factor-H-related protein concentrations","volume":"108","author":"Cipriani","year":"2021","journal-title":"Am J Hum Genet"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2021.06.002","article-title":"Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration","volume":"108","author":"Lor\u00e9s-Motta","year":"2021","journal-title":"Am J Hum Genet"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1135490","article-title":"The human factor H protein family \u2013 an update","volume":"15","author":"S\u00e1ndor","year":"2024","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.04.008","article-title":"Factor H-related proteins determine complement-activating surfaces","volume":"36","author":"J\u00f3zsi","year":"2015","journal-title":"Trends Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.364471","article-title":"Factor H-related protein 4 activates complement by serving as a platform for the assembly of alternative pathway C3 convertase via its interaction with C3b protein","volume":"287","author":"Hebecker","year":"2012","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2015.06.021","article-title":"FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome","volume":"67","author":"Bernab\u00e9u-Herrero","year":"2015","journal-title":"Mol Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2022.03.117","article-title":"Complement Factor H related protein 1 and immune inflammatory disorders","volume":"145","author":"Li","year":"2022","journal-title":"Mol Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2003.12.002","article-title":"Complement inhibitor C4b-binding protein\u2014friend or foe in the innate immune system","volume":"40","author":"Blom","year":"2004","journal-title":"Mol Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2300333","article-title":"Diverse functions of C4b-binding protein in health and disease","volume":"211","author":"Werner","year":"2023","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.135.4.2661","article-title":"Purification and functional analysis of the polymorphic variants of the C3b\/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF)","volume":"135","author":"Seya","year":"1985","journal-title":"J Immunol (Baltimore Md.: 1950)"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(94)00157-V","article-title":"and C4b-binding protein serve as factor I-cofactors both encompassing inactivation of C3b and C4b","volume":"32","author":"Seya","year":"1995","journal-title":"Mol Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M102445200","article-title":"Structural requirements for the complement regulatory activities of C4BP*","volume":"276","author":"Blom","year":"2001","journal-title":"J Biol Chem"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.12.7612","article-title":"Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of C4b-binding protein1","volume":"176","author":"Sj\u00f6berg","year":"2006","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.585361","article-title":"C4b binding protein acts as an innate immune effector against influenza A virus","volume":"11","author":"Varghese","year":"2021","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1149822","article-title":"C4b-binding protein inhibits particulate- and crystalline-induced NLRP3 inflammasome activation","volume":"14","author":"Bierschenk","year":"2023","journal-title":"Front Immunol"},{"key":"B69","article-title":"C4 binding protein deficiency in a patient with atypical Beh\u00e7et\u2019s disease","volume":"14","author":"Trapp","year":"1987","journal-title":"J Rheumatol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s0167-5699(98)01376-0","article-title":"Does properdin crosslink the cellular and the humoral immune response","volume":"20","author":"Schwaeble","year":"1999","journal-title":"Immunol Today"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1126\/science.120.3112.279","article-title":"The properdin system and immunity: I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena","volume":"120","author":"Pillemer","year":"1954","journal-title":"Science"},{"key":"B72","article-title":"Chapter 27 - properdin","volume-title":"The Complement FactsBook","author":"Ferreira","year":"2018"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M508928200","article-title":"The role of properdin in the assembly of the alternative pathway C3 convertases of complement*","volume":"281","author":"Hourcade","year":"2006","journal-title":"J Biol Chem"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1084\/jem.144.4.1076","article-title":"Alternative pathway of complement: recruitment of precursor properdin by the labile C3\/C5 convertase and the potentiation of the pathway","volume":"144","author":"Medicus","year":"1976","journal-title":"J Exp Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198704093161506","article-title":"Familial properdin deficiency and fatal meningococcemia. Correction of the bactericidal defect by vaccination","volume":"316","author":"Densen","year":"1987","journal-title":"N Engl J Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1990.tb05350.x","article-title":"Prevalence of hereditary properdin, C7 and C8 deficiencies in patients with meningococcal infections","volume":"81","author":"Schlesinger","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.01057.x","article-title":"Properdin deficiency and meningococcal disease\u2013identifying those most at risk","volume":"118","author":"Linton","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-5890(99)00107-8","article-title":"Properdin deficiency: molecular basis and disease association","volume":"36","author":"Fijen","year":"1999","journal-title":"Mol Immunol"},{"key":"B79","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-383834-6.00085-9","article-title":"Chapter 81 - inherited complement deficiencies","volume-title":"Emery and Rimoin\u2019s Principles and Practice of Medical Genetics","author":"Sullivan","year":"2013"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.151.4.2159","article-title":"Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9","volume":"151","author":"Tschopp","year":"1993","journal-title":"J Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1330095","article-title":"Complement C7 and clusterin form a complex in circulation","volume":"15","author":"Massri","year":"2024","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1365-2249.2006.03135.x","article-title":"Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC)","volume":"145","author":"Chauhan","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-12941","article-title":"Clusterin and complement activation in exfoliation glaucoma","volume":"55","author":"Doudevski","year":"2014","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B84","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1006\/excr.1999.4459","article-title":"A reexamination of the role of clusterin as a complement regulator","volume":"249","author":"Hochgrebe","year":"1999","journal-title":"Exp Cell Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(99)00005-9","article-title":"Vitronectin","volume":"31","author":"Schvartz","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1993.tb05956.x","article-title":"Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9","volume":"92","author":"Milis","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.26.12426","article-title":"Vitronectin is not essential for normal mammalian development and fertility","volume":"92","author":"Zheng","year":"1995","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2010.07373.x","article-title":"Vitronectin in bacterial pathogenesis: a host protein used in complement escape and cellular invasion","volume":"78","author":"Singh","year":"2010","journal-title":"Mol Microbiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1067\/msy.2000.105858","article-title":"Vitronectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice","volume":"127","author":"Jang","year":"2000","journal-title":"Surgery"},{"key":"B90","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/iep.12306","article-title":"Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model","volume":"100","author":"Hayashida","year":"2019","journal-title":"Int J Exp Pathol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1084\/jem.152.1.20","article-title":"Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte","volume":"152","author":"Fearon","year":"1980","journal-title":"J Exp Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.mchd-0034-2016","article-title":"Complement receptors in myeloid cell adhesion and phagocytosis","volume":"4","author":"Dustin","year":"2016","journal-title":"Microbiol Spectr"},{"key":"B93","first-page":"17","article-title":"Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21)","volume":"2","author":"Kazatchkine","year":"1990","journal-title":"Immunodefic Rev"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s00418-011-0799-x","article-title":"The follicular dendritic cell network in secondary follicles of human palatine tonsils and spleens","volume":"135","author":"Steiniger","year":"2011","journal-title":"Histochem Cell Biol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.molimm.2012.07.002","article-title":"Human complement receptor 2 (CR2\/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE)","volume":"53","author":"Asokan","year":"2013","journal-title":"Mol Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1084\/jem.158.4.1021","article-title":"Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody","volume":"158","author":"Iida","year":"1983","journal-title":"J Exp Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2005.04.006","article-title":"The complement receptor 1, CR1 (CD35), mediates inhibitory signals in human T-lymphocytes","volume":"43","author":"Wagner","year":"2006","journal-title":"Mol Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.620427","article-title":"Revisiting the coreceptor function of complement receptor type 2 (CR2, CD21); coengagement with the B-cell receptor inhibits the activation, proliferation, and antibody production of human B cells","volume":"12","author":"Kov\u00e1cs","year":"2021","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02716","article-title":"Structural immunology of complement receptors 3 and 4","volume":"9","author":"Vorup-Jensen","year":"2018","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2012.07.031","article-title":"CR3 is the dominant phagocytotic complement receptor on human dendritic cells","volume":"218","author":"S\u00e1ndor","year":"2013","journal-title":"Immunobiology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200104)31:4<1173::AID-IMMU1173>3.0.CO;2-9","article-title":"The complement receptor 3, CR3 (CD11b\/CD18), on T lymphocytes: activation-dependent up-regulation and regulatory function","volume":"31","author":"Wagner","year":"2001","journal-title":"Eur J Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(90)90041-W","article-title":"Contribution of CR3, CD11b\/CD18 to cytolysis by human NK cells","volume":"27","author":"Klein","year":"1990","journal-title":"Mol Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.138.1.254","article-title":"Cellular distribution of complement receptor type 4 (CR4): expression on human platelets","volume":"138","author":"Vik","year":"1987","journal-title":"J Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100256","article-title":"Complement receptor 3 mediates both sinking phagocytosis and phagocytic cup formation via distinct mechanisms","volume":"296","author":"Walbaum","year":"2021","journal-title":"J Biol Chem"},{"key":"B105","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.imlet.2017.05.014","article-title":"The role of CR3 (CD11b\/CD18) and CR4 (CD11c\/CD18) in complement-mediated phagocytosis and podosome formation by human phagocytes","volume":"189","author":"Luk\u00e1csi","year":"2017","journal-title":"Immunol Lett"},{"key":"B106","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1074-7613(02)00328-X","article-title":"CR3 (CD11b\/CD18) and CR4 (CD11c\/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans","volume":"16","author":"Taborda","year":"2002","journal-title":"Immunity"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e06-09-0813","article-title":"An essential role for talin during \u03b1M\u03b22-mediated phagocytosis","volume":"18","author":"Lim","year":"2007","journal-title":"Mol Biol Cell"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(87)90100-3","article-title":"Human diseases associated with C3 receptor deficiencies","volume":"14","author":"Kazatchkine","year":"1987","journal-title":"Immunol Lett"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02010","article-title":"CR4 signaling contributes to a DC-driven enhanced immune response against complement-opsonized HIV-1","volume":"11","author":"Bermejo-Jambrina","year":"2020","journal-title":"Front Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/nature05263","article-title":"Structure of C3b in complex with CRIg gives insights into regulation of complement activation","volume":"444","author":"Wiesmann","year":"2006","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.11.7902","article-title":"Complement receptor of the Ig superfamily enhances complement-mediated phagocytosis in a subpopulation of tissue resident macrophages","volume":"181","author":"Gorgani","year":"2008","journal-title":"J Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.chom.2016.06.002","article-title":"CRIg functions as a macrophage pattern recognition receptor to directly bind and capture blood-borne gram-positive bacteria","volume":"20","author":"Zeng","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25673","article-title":"VSIG4, a B7 family\u2013related protein, is a negative regulator of T cell activation","volume":"116","author":"Vogt","year":"2006","journal-title":"J Clin Invest"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.me.38.020187.001135","article-title":"Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p 150, 95 glycoproteins","volume":"38","author":"Anderson","year":"1987","journal-title":"Annu Rev Med"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2021.04.005","article-title":"Membrane cofactor protein (MCP; CD46): deficiency states and pathogen connections","volume":"72","author":"Liszewski","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4049\/jimmunol.1900527","article-title":"Complement in motion: the evolution of CD46 from a complement regulator to an orchestrator of normal cell physiology","volume":"203","author":"Liszewski","year":"2019","journal-title":"J Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40246-015-0029-z","article-title":"Complement regulator CD46: genetic variants and disease associations","volume":"9","author":"Liszewski","year":"2015","journal-title":"Hum Genomics"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2135497100","article-title":"Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome","volume":"100","author":"Richards","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01408.x","article-title":"Tears contain the complement regulator CD59 as well as decay-accelerating factor (DAF)","volume":"123","author":"Cocuzzi","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.4110\/in.2018.18.e11","article-title":"Beyond the role of CD55 as a complement component","volume":"18","author":"Dho","year":"2018","journal-title":"Immune Netw"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250147","article-title":"Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement","volume":"25","author":"Marschang","year":"1995","journal-title":"Eur J Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600631","article-title":"Distinct CD55 isoform synthesis and inhibition of complement-dependent cytolysis by hepatitis C virus","volume":"197","author":"Kwon","year":"2016","journal-title":"J Immunol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.2.1070","article-title":"Costimulation via CD55 on human CD4+ T cells mediated by CD97","volume":"177","author":"Capasso","year":"2006","journal-title":"J Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.149.6.2055","article-title":"Decay-accelerating factor expression on either effector or target cells inhibits cytotoxicity by human natural killer cells","volume":"149","author":"Finberg","year":"1992","journal-title":"J Immunol (Baltimore Md.: 1950)"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1717","article-title":"Diagnosis and management of paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Parker","year":"2005","journal-title":"Blood"},{"key":"B126","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/imr.12715","article-title":"CHAPLE syndrome uncovers the primary role of complement in a familial form of Waldmann\u2019s disease","volume":"287","author":"Ozen","year":"2019","journal-title":"Immunol Rev"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2006.09.008","article-title":"The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias","volume":"6","author":"Ruiz-Arg\u00fcelles","year":"2007","journal-title":"Autoimmun Rev"},{"key":"B128","article-title":"Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues","volume":"65","author":"Meri","year":"1991","journal-title":"Lab Invest"},{"key":"B129","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/s41467-023-36441-z","article-title":"Structural basis for membrane attack complex inhibition by CD59","volume":"14","author":"Couves","year":"2023","journal-title":"Nat Commun"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.155.9.4376","article-title":"Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia\/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV)","volume":"155","author":"Spear","year":"1995","journal-title":"J Immunol (Baltimore Md.: 1950)"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.10.5222","article-title":"Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q","volume":"168","author":"McGreal","year":"2002","journal-title":"J Immunol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/S0171-2985(98)80031-4","article-title":"C1q receptors: regulating specific functions of phagocytic cells","volume":"199","author":"Tenner","year":"1998","journal-title":"Immunobiology"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0809736106","article-title":"CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche","volume":"106","author":"Chevrier","year":"2009","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-010-9426-1","article-title":"Flow cytometric identification of CD93 expression on naive T lymphocytes (CD4(+)CD45RA (+) cells) in human neonatal umbilical cord blood","volume":"30","author":"Ikewaki","year":"2010","journal-title":"J Clin Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.169830","article-title":"CD93 maintains endothelial barrier function and limits metastatic dissemination","volume":"9","author":"Vemuri","year":"2024","journal-title":"JCI Insight"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.6.3406","article-title":"Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis","volume":"172","author":"Norsworthy","year":"2004","journal-title":"J Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.6.3583","article-title":"C1qRP is a heavily O-glycosylated cell surface protein involved in the regulation of phagocytic activity","volume":"162","author":"Nepomuceno","year":"1999","journal-title":"J Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3390\/cells12131778","article-title":"Role of CD93 in health and disease","volume":"12","author":"Tossetta","year":"2023","journal-title":"Cells"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/S0162-3109(00)80301-X","article-title":"C1q: structure, function, and receptors","volume":"49","author":"Kishore","year":"2000","journal-title":"Immunopharmacology"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01218.x","article-title":"C1q receptors","volume":"120","author":"Eggleton","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/S0171-2985(98)80028-4","article-title":"Interaction of C1q and the collectins with the potential receptors calreticulin (cClqR\/collectin receptor) and megalin","volume":"199","author":"Sim","year":"1998","journal-title":"Immunobiology"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V116.21.3855.3855","article-title":"Mesenchymal stem cells express the surface receptor calreticulin (cC1qR) and complement C1q chemoattracts them","volume":"116","author":"Qiu","year":"2010","journal-title":"Blood"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2016.10.015","article-title":"N-Glycoform-dependent interactions of megalin with its ligands","volume":"1861","author":"Hirano","year":"2017","journal-title":"Biochim Biophys Acta (BBA) - Gen Subj"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012541","article-title":"Cytotoxic T cell expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) in viral hepatitis C-mediated hepatocellular carcinoma","volume":"23","author":"Hammad","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B145","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.mucimm.2023.08.003","article-title":"LAIR-1 limits macrophage activation in acute inflammatory lung injury","volume":"16","author":"Helou","year":"2023","journal-title":"Mucosal Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1212753109","article-title":"C1q limits dendritic cell differentiation and activation by engaging LAIR-1","volume":"109","author":"Son","year":"2012","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B147","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41598-017-00290-w","article-title":"Evidence for C1q-mediated crosslinking of CD33\/LAIR-1 inhibitory immunoreceptors and biological control of CD33\/LAIR-1 expression","volume":"7","author":"Son","year":"2017","journal-title":"Sci Rep"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01793","article-title":"Leukocyte associated immunoglobulin like receptor 1 regulation and function on monocytes and dendritic cells during inflammation","volume":"11","author":"Carvalheiro","year":"2020","journal-title":"Front Immunol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jaci.2021.05.042","article-title":"LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity","volume":"149","author":"Helou","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.10.021","article-title":"Immune checkpoint molecules on ILC2s as potential therapeutic targets for allergic diseases","volume":"149","author":"Morita","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00842","article-title":"LAIR-1 limits neutrophilic airway inflammation","volume":"10","author":"Kumawat","year":"2019","journal-title":"Front Immunol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/13.10.1283","article-title":"Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN","volume":"13","author":"Park","year":"2001","journal-title":"Int Immunol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0307124101","article-title":"The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen","volume":"101","author":"Kang","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwn128","article-title":"Cooperation of specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) and complement receptor type 3 (CR3) in the uptake of oligomannose-coated liposomes by macrophages","volume":"19","author":"Takagi","year":"2009","journal-title":"Glycobiology"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2014.01.004","article-title":"C-type lectin receptor SIGNR1 expressed on peritoneal phagocytic cells with an immature dendritic cell-like phenotype is involved in uptake of oligomannose-coated liposomes and subsequent cell maturation","volume":"287","author":"Kawauchi","year":"2014","journal-title":"Cell Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2008.11.070","article-title":"The C-type lectin CD209b is expressed on microglia and it mediates the uptake of capsular polysaccharides of Streptococcus pneumoniae","volume":"450","author":"Park","year":"2009","journal-title":"Neurosci Lett"},{"key":"B157","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cell.2006.01.046","article-title":"A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q","volume":"125","author":"Kang","year":"2006","journal-title":"Cell"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1044","article-title":"Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens","volume":"100","author":"Geijtenbeek","year":"2002","journal-title":"vivo. Blood"},{"key":"B159","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cell.2006.03.018","article-title":"Emerging patterns in complement-mediated pathogen recognition","volume":"125","author":"Roozendaal","year":"2006","journal-title":"Cell"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2014.09.001","article-title":"Structural basis for selective recognition of endogenous and microbial polysaccharides by macrophage receptor SIGN-R1","volume":"22","author":"Silva-Mart\u00edn","year":"2014","journal-title":"Structure"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2012.160","article-title":"SIGN-R1, a C-type lectin, enhances apoptotic cell clearance through the complement deposition pathway by interacting with C1q in the spleen","volume":"20","author":"Prabagar","year":"2013","journal-title":"Cell Death Differentiation"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.06.059","article-title":"SIGN-R1 and complement factors are involved in the systemic clearance of radiation-induced apoptotic cells in whole-body irradiated mice","volume":"463","author":"Park","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1921673117","article-title":"Marginal zone SIGN-R1+ macrophages are essential for the maturation of germinal center B cells in the spleen","volume":"117","author":"Pirgova","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2008.01.032","article-title":"Interaction of SIGNR1 expressed by marginal zone macrophages with marginal zone B cells is essential to early IgM responses against Streptococcus pneumoniae","volume":"45","author":"Koppel","year":"2008","journal-title":"Mol Immunol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.4.3.359","article-title":"Infectious diseases associated with complement deficiencies","volume":"4","author":"Figueroa","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"B166","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-597640-4.50004-3","article-title":"Introduction and history of complement research","volume-title":"Immunobiology of the Complement System","author":"Ross","year":"1986"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2007.02.006","article-title":"Complement and coagulation: strangers or partners in crime","volume":"28","author":"Markiewski","year":"2007","journal-title":"Trends Immunol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.147.3.921","article-title":"Proteolysis of C3 on U937 cell plasma membranes","volume":"147","author":"Maison","year":"1991","journal-title":"Purification cathepsin G. J Immunol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a135262","article-title":"Limited proteolysis of a chemically modified third component of human complement, C3, by cathepsin G of human leukocytes","volume":"98","author":"Matsuda","year":"1985","journal-title":"J Biochem"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.018","article-title":"Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation","volume":"39","author":"Liszewski","year":"2013","journal-title":"Immunity"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.11.015","article-title":"New twist on an ancient innate immune pathway","volume":"39","author":"Lajoie","year":"2013","journal-title":"Immunity"},{"key":"B172","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.intimp.2018.12.002","article-title":"The mTORC1 signaling modulated by intracellular C3 activation in Paneth cells promotes intestinal epithelial regeneration during acute injury","volume":"67","author":"Ye","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00587","article-title":"The paneth cell: the curator and defender of the immature small intestine","volume":"11","author":"Lueschow","year":"2020","journal-title":"Front Immunol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-005-0202-x","article-title":"Paneth cell alpha-defensins: peptide mediators of innate immunity in the small intestine","volume":"27","author":"Ouellette","year":"2005","journal-title":"Springer Semin Immunopathol"},{"key":"B175","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00018-022-04308-z","article-title":"Alternative translation and retrotranslocation of cytosolic C3 that detects cytoinvasive bacteria","volume":"79","author":"Kremlitzka","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2312621121","article-title":"Intracellular C3 protects \u03b2-cells from IL-1\u03b2-driven cytotoxicity via interaction with Fyn-related kinase","volume":"121","author":"Kulak","year":"2024","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20040285","article-title":"The tyrosine kinase FRK\/RAK participates in cytokine-induced islet cell cytotoxicity","volume":"382","author":"Welsh","year":"2004","journal-title":"Biochem J"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1210\/en.2017-00104","article-title":"Protective role of complement C3 against cytokine-mediated \u03b2-cell apoptosis","volume":"158","author":"Dos Santos","year":"2017","journal-title":"Endocrinology"},{"key":"B179","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2023.12.019","article-title":"Complement in breast milk modifies offspring gut microbiota to promote infant health","volume":"187","author":"Xu","year":"2024","journal-title":"Cell"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01006-8","article-title":"Complement in maternal milk shapes the infant microbiome","volume":"24","author":"Papatriantafyllou","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1084\/jem.186.2.199","article-title":"The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes","volume":"186","author":"Martin","year":"1997","journal-title":"J Exp Med"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1999.00764.x","article-title":"Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies","volume":"97","author":"Zwirner","year":"1999","journal-title":"Immunology"},{"key":"B183","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.molimm.2017.05.019","article-title":"Novel insights into the expression pattern of anaphylatoxin receptors in mice and men","volume":"89","author":"Laumonnier","year":"2017","journal-title":"Mol Immunol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.etp.2007.03.004","article-title":"Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in rat and murine models of lung inflammation","volume":"58","author":"Tschernig","year":"2007","journal-title":"Exp Toxicologic Pathol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-502229","article-title":"C3a modulates IL-1\u03b2 secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation","volume":"122","author":"Asgari","year":"2013","journal-title":"Blood"},{"key":"B186","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/imcb.12534","article-title":"Differentiation of human macrophages with anaphylatoxin C3a impairs alternative M2 polarization and decreases lipopolysaccharide-induced cytokine secretion","volume":"100","author":"Mogilenko","year":"2022","journal-title":"Immunol Cell Biol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.314150","article-title":"Protective role of C3aR (C3a anaphylatoxin receptor) against atherosclerosis in atherosclerosis-prone mice","volume":"40","author":"Wei","year":"2020","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B188","doi-asserted-by":"publisher","first-page":"688","DOI":"10.4049\/jimmunol.1700318","article-title":"Monitoring C3aR expression using a floxed tdTomato-C3aR reporter knock-in mouse","volume":"199","author":"Quell","year":"2017","journal-title":"J Immunol"},{"key":"B189","doi-asserted-by":"publisher","first-page":"11037","DOI":"10.1038\/ncomms11037","article-title":"Coagulation induced by C3aR-dependent NETosis drives protumorigenic neutrophils during small intestinal tumorigenesis","volume":"7","author":"Guglietta","year":"2016","journal-title":"Nat Commun"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.7.3543","article-title":"The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis","volume":"160","author":"Gasque","year":"1998","journal-title":"J Immunol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010657","article-title":"C3aR plays both sides in regulating resistance to bacterial infections","volume":"18","author":"Corcoran","year":"2022","journal-title":"PLoS Pathog"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98254","article-title":"Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2","volume":"4","author":"Brennan","year":"2019","journal-title":"JCI Insight"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1218815110","article-title":"The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization","volume":"110","author":"Wu","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2001.01197.x","article-title":"Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin","volume":"103","author":"Kirchhoff","year":"2001","journal-title":"Immunology"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2011.02.003","article-title":"Expression of complement components, receptors and regulators by human dendritic cells","volume":"48","author":"Li","year":"2011","journal-title":"Mol Immunol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-095018","article-title":"Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a\u2013C3aR interaction","volume":"111","author":"Peng","year":"2008","journal-title":"Blood"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-156646","article-title":"Cyclic AMP plays a critical role in C3a-receptor\u2013mediated regulation of dendritic cells in antigen uptake and T-cell stimulation","volume":"112","author":"Li","year":"2008","journal-title":"Blood"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2004.01829.x","article-title":"Human monocyte-derived dendritic cells are chemoattracted to C3a after up-regulation of the C3a receptor with interferons","volume":"111","author":"Gutzmer","year":"2004","journal-title":"Immunology"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.7.3783","article-title":"Characterization of synthetic C3a analog peptides on human eosinophils in comparison to the native complement component C3a1","volume":"164","author":"Petering","year":"2000","journal-title":"J Immunol"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1159\/000236743","article-title":"Degranulation from human eosinophils stimulated with C3a and C5a","author":"Takafuji","year":"1994","journal-title":"Int Arch Allergy Immunol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.6.2119","article-title":"C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation","volume":"181","author":"Daffern","year":"1995","journal-title":"J Exp Med"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830240304","article-title":"C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils","volume":"24","author":"Elsner","year":"1994","journal-title":"Eur J Immunol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1159\/000235350","article-title":"Regulation of mediator release by human basophils: importance of the sequence and time of addition in the combined action of different agonists","volume":"94","author":"Dahinden","year":"1991","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830230239","article-title":"Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a","volume":"23","author":"Kretzschmar","year":"1993","journal-title":"Eur J Immunol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.imlet.2009.10.007","article-title":"Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a","volume":"128","author":"Ali","year":"2010","journal-title":"Immunol Lett"},{"key":"B206","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2172-9-29","article-title":"Mast cell activation is characterized by upregulation of a functional anaphylatoxin C5a receptor","volume":"9","author":"Soruri","year":"2008","journal-title":"BMC Immunol"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022559","article-title":"Regulation of C3a receptor signaling in human mast cells by G protein coupled receptor kinases","volume":"6","author":"Guo","year":"2011","journal-title":"PLoS One"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1111\/all.14413","article-title":"Mast cells and complement system: Ancient interactions between components of innate immunity","volume":"75","author":"Elieh Ali Komi","year":"2020","journal-title":"Allergy"},{"key":"B209","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41467-017-00414-w","article-title":"Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a","volume":"8","author":"Lohman","year":"2017","journal-title":"Nat Commun"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034600","article-title":"Functional relevance of the anaphylatoxin receptor C3aR for platelet function and arterial thrombus formation marks an intersection point between innate immunity and thrombosis","volume":"138","author":"Sauter","year":"2018","journal-title":"Circulation"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2014.12.002","article-title":"Expression of anaphylatoxin receptors on platelets in patients with coronary heart disease","volume":"238","author":"Patzelt","year":"2015","journal-title":"Atherosclerosis"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1084\/jem.158.2.603","article-title":"Human platelet activation by C3a and C3a des-arg","volume":"158","author":"Polley","year":"1983","journal-title":"J Exp Med"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2014.03.018","article-title":"Expression and regulation of complement receptors by human natural killer cells","volume":"219","author":"Min","year":"2014","journal-title":"Immunobiology"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-21-0435","article-title":"C3aR signaling inhibits NK-cell infiltration into the tumor microenvironment in mouse models","volume":"10","author":"Nandagopal","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-22-0069","article-title":"The combination of radiotherapy and complement C3a inhibition potentiates natural killer cell functions against pancreatic cancer","volume":"2","author":"Sodji","year":"2022","journal-title":"Cancer Res Commun"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.02.001","article-title":"Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells","volume":"28","author":"Strainic","year":"2008","journal-title":"Immunity"},{"key":"B217","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.molimm.2013.11.010","article-title":"Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation","volume":"58","author":"Ghannam","year":"2014","journal-title":"Mol Immunol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.11.6599","article-title":"Activated human T lymphocytes express a functional C3a receptor1","volume":"165","author":"Werfel","year":"2000","journal-title":"J Immunol"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20121525","article-title":"Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells","volume":"210","author":"Kwan","year":"2013","journal-title":"J Exp Med"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.08.003","article-title":"Complement-mediated regulation of metabolism and basic cellular processes","volume":"45","author":"Hess","year":"2016","journal-title":"Immunity"},{"key":"B221","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/s0166-2236(98)01390-3","article-title":"Complement anaphylatoxin receptors on neurons: new tricks for old receptors","volume":"22","author":"Nataf","year":"1999","journal-title":"Trends Neurosci"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1136(199905)26:3<201::AID-GLIA2>3.0.CO;2-M","article-title":"Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells","volume":"26","author":"Davoust","year":"1999","journal-title":"Glia"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1998.71062487.x","article-title":"Expression of a functional anaphylatoxin C3a receptor by astrocytes","volume":"71","author":"Ischenko","year":"1998","journal-title":"J Neurochem"},{"key":"B224","doi-asserted-by":"publisher","first-page":"2350815","DOI":"10.1002\/eji.202350815","article-title":"Complement C3aR signaling: Immune and metabolic modulation and its impact on Alzheimer\u2019s disease","volume":"54","author":"Gedam","year":"2024","journal-title":"Eur J Immunol"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.4.2102","article-title":"Complement C3a and C5a induce different signal transduction cascades in endothelial cells1","volume":"169","author":"Schraufstatter","year":"2002","journal-title":"J Immunol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.002639","article-title":"Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells","volume":"293","author":"Sartain","year":"2018","journal-title":"J Biol Chem"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201902397R","article-title":"In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells","volume":"34","author":"Shivshankar","year":"2020","journal-title":"FASEB J"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140966","article-title":"Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging","volume":"131","author":"Propson","year":"2021","journal-title":"J Clin Invest"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252011240","article-title":"C3a Mediates Endothelial Barrier Disruption in Brain-Derived, but Not Retinal, Human Endothelial Cells","volume":"25","author":"Wolf","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B230","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1186\/s12967-023-04764-6","article-title":"C3a\/C3aR synergies with TGF-\u03b2 to promote epithelial-mesenchymal transition of renal tubular epithelial cells via the activation of the NLRP3 inflammasome","volume":"21","author":"You","year":"2023","journal-title":"J Transl Med"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.628062","article-title":"Mitochondrial C3a receptor activation in oxidatively stressed epithelial cells reduces mitochondrial respiration and metabolism","volume":"12","author":"Ishii","year":"2021","journal-title":"Front Immunol"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v7.i8.1090","article-title":"Complement activation in the context of stem cells and tissue repair","volume":"7","author":"Schraufstatter","year":"2015","journal-title":"World J Stem Cells"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00946-w","article-title":"Complement-in\u2019 the germinal center response","volume":"22","author":"Robinson","year":"2021","journal-title":"Nat Immunol"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00926-0","article-title":"Dynamic regulation of B cell complement signaling is integral to germinal center responses","volume":"22","author":"Cumpelik","year":"2021","journal-title":"Nat Immunol"},{"key":"B235","doi-asserted-by":"publisher","first-page":"152413","DOI":"10.1016\/j.imbio.2023.152413","article-title":"The role of C5a receptors in autoimmunity","volume":"228","author":"Schanzenbacher","year":"2023","journal-title":"Immunobiology"},{"key":"B236","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.intimp.2017.10.006","article-title":"C5a\/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression","volume":"53","author":"Zhang","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00368","article-title":"New insights for C5a and C5a receptors in sepsis","volume":"3","author":"Gao","year":"2012","journal-title":"Front Immunol"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0403137","article-title":"A key role of C5a\/C5aR activation for the development of sepsis","volume":"74","author":"Riedemann","year":"2003","journal-title":"J Leukoc Biol"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1038\/nri1269","article-title":"The dark side of C5a in sepsis","volume":"4","author":"Ward","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1096\/fj.12-220509","article-title":"C5L2: a controversial receptor of complement anaphylatoxin, C5a","volume":"27","author":"Li","year":"2013","journal-title":"FASEB J"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2008.11.001","article-title":"The human complement fragment receptor, C5L2, is a recycling decoy receptor","volume":"46","author":"Scola","year":"2009","journal-title":"Mol Immunol"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2009.06.007","article-title":"C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation","volume":"46","author":"Cui","year":"2009","journal-title":"Mol Immunol"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2012.10.005","article-title":"Differential chemoattractant response in adipocytes and macrophages to the action of acylation stimulating protein","volume":"92","author":"Tom","year":"2013","journal-title":"Eur J Cell Biol"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2013.10.019","article-title":"C5aR and C5L2 act in concert to balance immunometabolism in adipose tissue","volume":"382","author":"Poursharifi","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2009.08.013","article-title":"Recombinant C3adesArg\/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation","volume":"46","author":"Cui","year":"2009","journal-title":"Mol Immunol"},{"key":"B246","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1476-511X-13-75","article-title":"A novel mutation in C5L2 gene was associated with hyperlipidemia and retinitis pigmentosa in a Chinese family","volume":"13","author":"Qu","year":"2014","journal-title":"Lipids Health Dis"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C100714200","article-title":"The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-arg74*","volume":"277","author":"Cain","year":"2002","journal-title":"J Biol Chem"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-5890(00)00067-5","article-title":"A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells","volume":"37","author":"Ohno","year":"2000","journal-title":"Mol Immunol"},{"key":"B249","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0169-328X(00)00242-4","article-title":"Identification of four novel human G protein-coupled receptors expressed in the brain","volume":"86","author":"Lee","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-3424fje","article-title":"Evidence for a functional role of the second C5a receptor C5L2","volume":"19","author":"Gao","year":"2005","journal-title":"FASEB J"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1038\/nature05559","article-title":"C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a","volume":"446","author":"Chen","year":"2007","journal-title":"Nature"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M406921200","article-title":"C5L2 is a functional receptor for acylation-stimulating protein","volume":"280","author":"Kalant","year":"2005","journal-title":"J Biol Chem"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1038\/sj.icb.7100166","article-title":"Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2","volume":"86","author":"Lee","year":"2008","journal-title":"Immunol Cell Biol"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700710","article-title":"Monitoring C5aR2 expression using a floxed tdTomato-C5aR2 knock-in mouse","volume":"199","author":"Karsten","year":"2017","journal-title":"J Immunol"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401401","article-title":"Monitoring and cell-specific deletion of C5aR1 using a novel floxed GFP-C5aR1 reporter knock-in mouse","volume":"194","author":"Karsten","year":"2015","journal-title":"J Immunol"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1197709","article-title":"The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita","volume":"14","author":"Seiler","year":"2023","journal-title":"Front Immunol"},{"key":"B257","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.imlet.2019.03.014","article-title":"Differential effects of anaphylatoxin C5a on antigen presenting cells, roles for C5aR1 and C5aR2","volume":"209","author":"Zaal","year":"2019","journal-title":"Immunol Lett"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00818","article-title":"Anaphylatoxin C5a regulates 6-sulfo-lacNAc dendritic cell function in human through crosstalk with toll-like receptor-induced CREB signaling","volume":"8","author":"Zaal","year":"2017","journal-title":"Front Immunol"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)94252-3","article-title":"Characterization of a receptor for C5a anaphylatoxin on human eosinophils","volume":"264","author":"Gerard","year":"1989","journal-title":"J Biol Chem"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.2.1127","article-title":"A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo1","volume":"162","author":"DiScipio","year":"1999","journal-title":"J Immunol"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830260723","article-title":"Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies","volume":"26","author":"Elsner","year":"1996","journal-title":"Eur J Immunol"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.092106","article-title":"The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction*","volume":"285","author":"Bamberg","year":"2010","journal-title":"J Biol Chem"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000892","article-title":"A critical role for C5L2 in the pathogenesis of experimental allergic asthma","volume":"185","author":"Zhang","year":"2010","journal-title":"J Immunol"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.155.6.3152","article-title":"Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88\/C5aR expression on skin mast cells","volume":"155","author":"F\u00fcreder","year":"1995","journal-title":"J Immunol"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113403","article-title":"Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release","volume":"81","author":"Schulman","year":"1988","journal-title":"J Clin Invest"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.4.2183","article-title":"Requirements for C5a receptor-mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils","volume":"165","author":"Eglite","year":"2000","journal-title":"J Immunol"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.157.4.1693","article-title":"C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway","volume":"157","author":"Nilsson","year":"1996","journal-title":"J Immunol"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.8.2863","article-title":"C3a and C5a stimulate chemotaxis of human mast cells","volume":"89","author":"Hartmann","year":"1997","journal-title":"Blood"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12378589","article-title":"Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells","volume":"102","author":"el-Lati","year":"1994","journal-title":"J Invest Dermatol"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401348","article-title":"The novel receptor C5aR2 is required for C5a-mediated human mast cell adhesion, migration, and proinflammatory mediator production","volume":"195","author":"Pundir","year":"2015","journal-title":"J Immunol"},{"key":"B271","doi-asserted-by":"publisher","first-page":"P25","DOI":"10.1186\/1710-1492-6-S2-P25","article-title":"The seven-transmembrane receptor, C5L2, is a stimulatory receptor on human mast cells","volume":"6","author":"Pundir","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B272","doi-asserted-by":"crossref","first-page":"AB239","DOI":"10.1016\/j.jaci.2012.12.1518","article-title":"Functional expression of the novel C5a receptor C5L2 in human mast cells","volume":"131","author":"Pundir","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B273","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1038\/s41467-021-23499-w","article-title":"The C5a\/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets","volume":"12","author":"Nording","year":"2021","journal-title":"Nat Commun"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.126.4.1506","article-title":"Platelet-serotonin release by C3a and C5a: two independent pathways of activation","volume":"126","author":"Meuer","year":"1981","journal-title":"J Immunol"},{"key":"B275","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41598-020-80685-4","article-title":"Platelet CXCL4 mediates neutrophil extracellular traps formation in ANCA-associated vasculitis","volume":"11","author":"Matsumoto","year":"2021","journal-title":"Sci Rep"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.834988","article-title":"Signaling through fc\u03b3RIIA and the C5a-C5aR pathway mediate platelet hyperactivation in COVID-19","volume":"13","author":"Apostolidis","year":"2022","journal-title":"Front Immunol"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005246","article-title":"C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19","volume":"6","author":"Aiello","year":"2022","journal-title":"Blood Adv"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210321","article-title":"Increased expression of anaphylatoxin C5a-receptor-1 in neutrophils and natural killer cells of preterm infants","volume":"24","author":"Boeckel","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100338","article-title":"C5a regulates NKT and NK cell functions in sepsis","volume":"187","author":"Fusakio","year":"2011","journal-title":"J Immunol"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201142290","article-title":"Complement regulates conventional DC-mediated NK-cell activation by inducing TGF-\u03b21 in Gr-1+ myeloid cells","volume":"42","author":"Qing","year":"2012","journal-title":"Eur J Immunol"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2011.03445.x","article-title":"\u03b3\u03b4T-cell function in sepsis is modulated by C5a receptor signalling","volume":"133","author":"Han","year":"2011","journal-title":"Immunology"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000384R","article-title":"C5a\/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from \u03b3\u03b4-T cells","volume":"34","author":"Zheng","year":"2020","journal-title":"FASEB J"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-151068","article-title":"Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis","volume":"112","author":"Lalli","year":"2008","journal-title":"Blood"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.7.4018","article-title":"Human T cells express the C5a receptor and are chemoattracted to C5a","volume":"162","author":"Nataf","year":"1999","journal-title":"J Immunol"},{"key":"B285","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.4.2524","article-title":"Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses1","volume":"173","author":"Kim","year":"2004","journal-title":"J Immunol"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.12.010","article-title":"Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8+ T cell activity","volume":"32","author":"Luan","year":"2024","journal-title":"Mol Ther"},{"key":"B287","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1471-4159.2010.06595.x","article-title":"Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer\u2019s disease","volume":"113","author":"Ager","year":"2010","journal-title":"J Neurochem"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2018-07.2007","article-title":"Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity","volume":"27","author":"Griffin","year":"2007","journal-title":"J Neurosci"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071812","article-title":"The complement system: A powerful modulator and effector of astrocyte function in the healthy and diseased central nervous system","volume":"10","author":"Pekna","year":"2021","journal-title":"Cells"},{"key":"B290","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5218-14.2015","article-title":"The complement receptor C5aR controls acute inflammation and astrogliosis following spinal cord injury","volume":"35","author":"Brennan","year":"2015","journal-title":"J Neurosci"},{"key":"B291","doi-asserted-by":"publisher","first-page":"7028","DOI":"10.1038\/s41467-024-51163-6","article-title":"C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u2019s disease mouse model","volume":"15","author":"Schartz","year":"2024","journal-title":"Nat Commun"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2016.4701","article-title":"The alternative receptor for complement component 5a, C5aR2, conveys neuroprotection in traumatic spinal cord injury","volume":"34","author":"Biggins","year":"2017","journal-title":"J Neurotrauma"},{"key":"B293","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12974-022-02539-2","article-title":"Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression","volume":"19","author":"Carvalho","year":"2022","journal-title":"J Neuroinflamm"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.10.5962","article-title":"Expression and function of C5a receptor in mouse microvascular endothelial cells","volume":"169","author":"Laudes","year":"2002","journal-title":"J Immunol"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2014.04.004","article-title":"High expression of C5L2 correlates with high proinflammatory cytokine expression in advanced human atherosclerotic plaques","volume":"184","author":"Vijayan","year":"2014","journal-title":"Am J Pathol"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707332","article-title":"Function, structure and therapeutic potential of complement C5a receptors","volume":"152","author":"Monk","year":"2007","journal-title":"Br J Pharmacol"},{"key":"B297","doi-asserted-by":"publisher","first-page":"110851","DOI":"10.1016\/j.celrep.2022.110851","article-title":"Intracellular complement C5a\/C5aR1 stabilizes \u03b2-catenin to promote colorectal tumorigenesis","volume":"39","author":"Ding","year":"2022","journal-title":"Cell Rep"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1101\/2023.01.10.521547","article-title":"Innate immune receptor C5aR1 regulates cancer cell fate and can be targeted to improve radiotherapy in tumours with immunosuppressive microenvironments","author":"Beach","year":"2023","journal-title":"bioRxiv"},{"key":"B299","doi-asserted-by":"publisher","first-page":"130374","DOI":"10.1016\/j.bbagen.2023.130374","article-title":"Anaphylatoxin C5a receptor signaling induces mitochondrial fusion and sensitizes retinal pigment epithelial cells to oxidative stress","volume":"1867","author":"Ishii","year":"2023","journal-title":"Biochim Biophys Acta (BBA) - Gen Subj"},{"key":"B300","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M609734200","article-title":"Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines","volume":"281","author":"Johswich","year":"2006","journal-title":"J Biol Chem"},{"key":"B301","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/(SICI)1097-0185(199609)246:1<78::AID-AR9>3.0.CO;2-B","article-title":"Human complement regulator expression by the normal female reproductive tract","volume":"246","author":"Oglesby","year":"1996","journal-title":"Anat Rec"},{"key":"B302","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0008-8749(03)00127-8","article-title":"Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells","volume":"223","author":"Iborra","year":"2003","journal-title":"Cell Immunol"},{"key":"B303","article-title":"Expression and role of complement regulatory proteins on human gametes and pre-implantation embryos","volume":"23","author":"F\u00e9nichel","year":"1995","journal-title":"Contracept Fertil Sex"},{"key":"B304","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1995.tb00879.x","article-title":"Expression of complement regulatory proteins on human eggs and preimplantation embryos","volume":"33","author":"Fenichel","year":"1995","journal-title":"Am J Reprod Immunol"},{"key":"B305","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/2.1.52","article-title":"Complement-binding proteins are strongly expressed by human preimplantation blastocysts and cumulus cells as well as gametes","volume":"2","author":"Taylor","year":"1996","journal-title":"Mol Hum Reprod"},{"key":"B306","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02234","article-title":"Complement in human pre-implantation embryos: attack and defense","volume":"10","author":"Reichhardt","year":"2019","journal-title":"Front Immunol"},{"key":"B307","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1998.tb00360.x","article-title":"Complement regulatory proteins on the sperm surface: relevance to sperm motility","volume":"39","author":"Jiang","year":"1998","journal-title":"Am J Reprod Immunol"},{"key":"B308","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.148.5.1431","article-title":"Identification and characterization of membrane cofactor protein of human spermatozoa","volume":"148","author":"Cervoni","year":"1992","journal-title":"J Immunol"},{"key":"B309","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2006.02374.x","article-title":"The complement regulatory proteins CD55 (decay accelerating factor) and CD59 are expressed on the inner acrosomal membrane of human spermatozoa as well as CD46 (membrane cofactor protein)","volume":"118","author":"Cummerson","year":"2006","journal-title":"Immunology"},{"key":"B310","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)55875-0","article-title":"The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury","volume":"59","author":"D\u2019Cruz","year":"1993","journal-title":"Fertil Steril"},{"key":"B311","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-0378(98)00006-0","article-title":"Detection of complement C1q receptors on human spermatozoa","volume":"38","author":"Bronson","year":"1998","journal-title":"J Reprod Immunol"},{"key":"B312","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod66.3.823","article-title":"Surface Expression of Complement Receptor gC1q-R\/p33 Is Increased on the Plasma Membrane of Human Spermatozoa after Capacitation1","volume":"66","author":"Grace","year":"2002","journal-title":"Biol Reprod"},{"key":"B313","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.21.10051","article-title":"The role of complement component C3b and its receptors in sperm-oocyte interaction","volume":"90","author":"Anderson","year":"1993","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B314","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23213","article-title":"Targeted and restricted complement activation on acrosome-reacted spermatozoa","volume":"115","author":"Riley-Vargas","year":"2005","journal-title":"J Clin Invest"},{"key":"B315","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2009.06.124","article-title":"Complement production by trophoblast cells at the feto-maternal interface","volume":"82","author":"Bulla","year":"2009","journal-title":"J Reprod Immunol"},{"key":"B316","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-02-0517","article-title":"CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells","volume":"102","author":"Hanna","year":"2003","journal-title":"Blood"},{"key":"B317","doi-asserted-by":"publisher","DOI":"10.1084\/jem.193.10.1199","article-title":"Human placental cytotrophoblasts attract monocytes and CD56(bright) natural killer cells via the actions of monocyte inflammatory protein 1alpha","volume":"193","author":"Drake","year":"2001","journal-title":"J Exp Med"},{"key":"B318","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030305","article-title":"Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential","volume":"198","author":"Koopman","year":"2003","journal-title":"J Exp Med"},{"key":"B319","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2005.12.006","article-title":"The uterine spiral arteries in human pregnancy: facts and controversies","volume":"27","author":"Pijnenborg","year":"2006","journal-title":"Placenta"},{"key":"B320","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.79.19.6003","article-title":"Inhibition of in vitro natural killer activity by the third component of complement: role for the C3a fragment","volume":"79","author":"Charriaut","year":"1982","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B321","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-200469","article-title":"Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model","volume":"114","author":"Wang","year":"2009","journal-title":"Blood"},{"key":"B322","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-074716","article-title":"NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement","volume":"111","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"B323","doi-asserted-by":"publisher","DOI":"10.1038\/nm1452","article-title":"Decidual NK cells regulate key developmental processes at the human fetal-maternal interface","volume":"12","author":"Hanna","year":"2006","journal-title":"Nat Med"},{"key":"B324","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2009.09.015","article-title":"Natural Killer cells: keepers of pregnancy in the turnstile of the environment","volume":"24","author":"Karimi","year":"2010","journal-title":"Brain Behav Immun"},{"key":"B325","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0507835102","article-title":"Human decidual NK cells form immature activating synapses and are not cytotoxic","volume":"102","author":"Kopcow","year":"2005","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B326","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903215","article-title":"An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development","volume":"185","author":"Agostinis","year":"2010","journal-title":"J Immunol"},{"key":"B327","doi-asserted-by":"publisher","DOI":"10.37349\/ei","article-title":"A non-redundant role of complement protein C1q in normal and adverse pregnancy","volume":"2","author":"Agostinis","year":"2022","journal-title":"Explor Immunol"},{"key":"B328","doi-asserted-by":"publisher","DOI":"10.1080\/19336918.2016.1170258","article-title":"Epithelial-mesenchymal transition during extravillous trophoblast differentiation","volume":"10","author":"E Davies","year":"2016","journal-title":"Cell Adh Migr"},{"key":"B329","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1681\/ASN.2008040434","article-title":"C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy","volume":"20","author":"Tang","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B330","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272917","article-title":"Twist-related protein 1 induces epithelial-mesenchymal transition and renal fibrosis through the upregulation of complement 3","volume":"17","author":"Otsuki","year":"2022","journal-title":"PLoS One"},{"key":"B331","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501886","article-title":"Complement component 3 is regulated by TWIST1 and mediates epithelial\u2013mesenchymal transition","volume":"196","author":"Cho","year":"2016","journal-title":"J Immunol"},{"key":"B332","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1477-7827-2-15","article-title":"Trophoblast \u2018pseudo-tumorigenesis\u2019: significance and contributory factors","volume":"2","author":"Soundararajan","year":"2004","journal-title":"Reprod Biol Endocrinol"},{"key":"B333","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.637594","article-title":"Autophagy process in trophoblast cells invasion and differentiation: similitude and differences with cancer cells","volume":"11","author":"Carvajal","year":"2021","journal-title":"Front Oncol"},{"key":"B334","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dml048","article-title":"Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts","volume":"13","author":"Ferretti","year":"2006","journal-title":"Hum Reprod Update"},{"key":"B335","doi-asserted-by":"publisher","DOI":"10.1080\/14767050500072722","article-title":"Normal pregnancy is characterized by systemic activation of the complement system","volume":"17","author":"Richani","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B336","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2010.01.021","article-title":"Activation of the complement system in normal pregnancy and preeclampsia","volume":"47","author":"Derzsy","year":"2010","journal-title":"Mol Immunol"},{"key":"B337","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1992.tb00787.x","article-title":"Activation of the complement pathway: comparison of normal pregnancy, preeclampsia, and systemic lupus erythematosus during pregnancy","volume":"28","author":"Abramson","year":"1992","journal-title":"Am J Reprod Immunol"},{"key":"B338","doi-asserted-by":"publisher","DOI":"10.1515\/JPM.2005.051","article-title":"Anaphylatoxins in preterm and term labor","volume":"33","author":"Soto","year":"2005","journal-title":"J Perinat Med"},{"key":"B339","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/AOG.0b013e3181fc3afa","article-title":"Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes","volume":"117","author":"Lynch","year":"2011","journal-title":"Obstet Gynecol"},{"key":"B340","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13202","article-title":"Normal range of complement components during pregnancy: A prospective study","volume":"83","author":"He","year":"2020","journal-title":"Am J Reprod Immunol"},{"key":"B341","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.918320","article-title":"Elevated adipsin and reduced C5a levels in the maternal serum and follicular fluid during implantation are associated with successful pregnancy in obese women","volume":"13","author":"Ramanjaneya","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B342","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.702385","article-title":"Adipsin of the alternative complement pathway is a potential predictor for preeclampsia in early pregnancy","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"B343","doi-asserted-by":"publisher","first-page":"20073","DOI":"10.1038\/srep20073","article-title":"Serum adipsin levels throughout normal pregnancy and preeclampsia","volume":"6","author":"Poveda","year":"2016","journal-title":"Sci Rep"},{"key":"B344","doi-asserted-by":"publisher","DOI":"10.1126\/science.2734615","article-title":"Adipsin and complement factor D activity: an immune-related defect in obesity","volume":"244","author":"Rosen","year":"1989","journal-title":"Science"},{"key":"B345","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.261428398","article-title":"Complement activation in factor D-deficient mice","volume":"98","author":"Xu","year":"2001","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B346","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042222","article-title":"Adipsin serum concentrations and adipose tissue expression in people with obesity and type 2 diabetes","volume":"23","author":"Milek","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B347","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cell.2014.06.005","article-title":"Adipsin is an adipokine that improves \u03b2 cell function in diabetes","volume":"158","author":"Lo","year":"2014","journal-title":"Cell"},{"key":"B348","doi-asserted-by":"publisher","first-page":"107270","DOI":"10.1016\/j.vph.2023.107270","article-title":"Adipsin in the pathogenesis of cardiovascular diseases","volume":"154","author":"Dare","year":"2024","journal-title":"Vasc Pharmacol"},{"key":"B349","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2010.07.004","article-title":"Functional analysis of the mannose-binding lectin complement pathway in normal pregnancy and preeclampsia","volume":"87","author":"Csuka","year":"2010","journal-title":"J Reprod Immunol"},{"key":"B350","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12439","article-title":"The relationship of longitudinal levels of complement bb during pregnancy with preeclampsia","volume":"75","author":"Lynch","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"B351","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.molimm.2015.02.030","article-title":"The complement system and adverse pregnancy outcomes","volume":"67","author":"Regal","year":"2015","journal-title":"Mol Immunol"},{"key":"B352","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/aji.12000","article-title":"Complement in pregnancy: a delicate balance","volume":"69","author":"Denny","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"B353","doi-asserted-by":"publisher","first-page":"154012","DOI":"10.1016\/j.metabol.2019.154012","article-title":"Effects of preeclampsia and eclampsia on maternal metabolic and biochemical outcomes in later life: a systematic review and meta-analysis","volume":"102","author":"Alonso-Ventura","year":"2020","journal-title":"Metabolism"},{"key":"B354","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2018.04.009","article-title":"Preeclampsia and the cardiovascular system: An update","volume":"28","author":"Perry","year":"2018","journal-title":"Trends Cardiovasc Med"},{"key":"B355","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2017.09.006","article-title":"Historical evolution of ideas on eclampsia\/preeclampsia: A proposed optimistic view of preeclampsia","volume":"123","author":"Robillard","year":"2017","journal-title":"J Reprod Immunol"},{"key":"B356","doi-asserted-by":"publisher","first-page":"S886","DOI":"10.1016\/j.ajog.2020.09.039","article-title":"Decidualization resistance in the origin of preeclampsia","volume":"226","author":"Garrido-G\u00f3mez","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"B357","doi-asserted-by":"publisher","first-page":"518.e511","DOI":"10.1016\/j.ajog.2020.11.004","article-title":"Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes","volume":"224","author":"Lai","year":"2021","journal-title":"Am J Obstetrics Gynecology"},{"key":"B358","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2011.09.011","article-title":"Maternal mortality from preeclampsia\/eclampsia","volume":"36","author":"Ghulmiyyah","year":"2012","journal-title":"Semin Perinatol"},{"key":"B359","doi-asserted-by":"publisher","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","article-title":"The etiology of preeclampsia","volume":"226","author":"Jung","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"B360","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.08.042","article-title":"Why is placentation abnormal in preeclampsia","volume":"213","author":"Fisher","year":"2015","journal-title":"Am J Obstetrics Gynecology"},{"key":"B361","doi-asserted-by":"publisher","first-page":"S786","DOI":"10.1016\/j.ajog.2021.12.001","article-title":"Preeclampsia and eclampsia: the conceptual evolution of a syndrome","volume":"226","author":"Erez","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"B362","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.98074","article-title":"Introductory chapter: macrophages \u2013 more than sentinel innate immune cells","volume-title":"Macrophages - Celebrating 140 Years of Discovery","author":"Kumar","year":"2022"},{"key":"B363","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0146-0005(99)80057-3","article-title":"The immunology of preeclampsia","volume":"23","author":"Dekker","year":"1999","journal-title":"Semin Perinatol"},{"key":"B364","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2010.00831.x","article-title":"Immunology of pre-eclampsia","volume":"63","author":"Redman","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"B365","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-023-01165-4","article-title":"Altered cytokine production in human intervillous blood T cells in preeclampsia","volume":"30","author":"Collier","year":"2023","journal-title":"Reprod Sci"},{"key":"B366","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jri.2012.01.006","article-title":"The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia","volume":"93","author":"Darmochwal-Kolarz","year":"2012","journal-title":"J Reprod Immunol"},{"key":"B367","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1272021","article-title":"High maternal-fetal HLA eplet compatibility is associated with severe manifestation of preeclampsia","volume":"14","author":"Stefa\u0144ska","year":"2023","journal-title":"Front Immunol"},{"key":"B368","doi-asserted-by":"publisher","first-page":"103074","DOI":"10.1016\/j.jri.2019.103074","article-title":"The development of preeclampsia in oocyte donation pregnancies is related to the number of fetal-maternal HLA class II mismatches","volume":"137","author":"van Bentem","year":"2020","journal-title":"J Reprod Immunol"},{"key":"B369","doi-asserted-by":"publisher","first-page":"100321","DOI":"10.1016\/j.xagr.2024.100321","article-title":"Immunologic aspects of preeclampsia","volume":"4","author":"Boulanger","year":"2024","journal-title":"AJOG Global Rep"},{"key":"B370","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2006.04.001","article-title":"Inflammation and pre-eclampsia","volume":"11","author":"Borzychowski","year":"2006","journal-title":"Semin Fetal Neonatal Med"},{"key":"B371","doi-asserted-by":"publisher","DOI":"10.1042\/BST20110672","article-title":"Is inflammation the cause of pre-eclampsia","volume":"39","author":"Ramma","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"B372","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.070166","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight","volume":"171","author":"Markiewski","year":"2007","journal-title":"Am J Pathol"},{"key":"B373","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11210","article-title":"Role of complement-related inflammation and vascular dysfunction in hypertension","volume":"73","author":"Ruan","year":"2019","journal-title":"Hypertension"},{"key":"B374","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2023.04.001","article-title":"Pre-eclampsia is associated with complement pathway activation in the maternal and fetal circulation, and placental tissue","volume":"32","author":"Blakey","year":"2023","journal-title":"Pregnancy Hypertension"},{"key":"B375","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jri.2014.12.002","article-title":"Complement factor B activation in patients with preeclampsia","volume":"109","author":"Velickovic","year":"2015","journal-title":"J Reprod Immunol"},{"key":"B376","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2008.00631.x","article-title":"A role for mannose-binding lectin, a component of the innate immune system in pre-eclampsia","volume":"60","author":"Than","year":"2008","journal-title":"Am J Reprod Immunol"},{"key":"B377","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.07.038","article-title":"Does race or ethnicity play a role in the origin, pathophysiology, and outcomes of preeclampsia? An expert review of the literature","volume":"226","author":"Johnson","year":"2022","journal-title":"Am J Obstetrics Gynecology"},{"key":"B378","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.10.793","article-title":"Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia","volume":"198","author":"Lynch","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"B379","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.915777","article-title":"Serum levels of complement factors C1q, bb, and H in normal pregnancy and severe pre-eclampsia","volume":"25","author":"Jia","year":"2019","journal-title":"Med Sci Monit"},{"key":"B380","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12541","article-title":"Expression of the complement system\u2019s activation factors in plasma of patients with early\/late-onset severe pre-eclampsia","volume":"76","author":"He","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"B381","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000440651","article-title":"Complement split products C3a\/C5a and receptors: are they regulated by circulating angiotensin II type 1 receptor autoantibody in severe preeclampsia","volume":"81","author":"Ye","year":"2016","journal-title":"Gynecol Obstet Invest"},{"key":"B382","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/10641955.2016.1190845","article-title":"Correlations between complement system\u2019s activation factors and anti-angiogenesis factors in plasma of patients with early\/late-onset severe preeclampsia","volume":"35","author":"He","year":"2016","journal-title":"Hypertens Pregnancy"},{"key":"B383","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2012.08.003","article-title":"Decreased expression of complement 3a receptor (C3aR) in human placentas from severe preeclamptic pregnancies","volume":"165","author":"Lim","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B384","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2011.01.003","article-title":"Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia","volume":"11","author":"LaMarca","year":"2011","journal-title":"Curr Opin Pharmacol"},{"key":"B385","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12072","article-title":"Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension","volume":"69","author":"Herse","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"B386","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/molehr\/gaw077","article-title":"Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis","volume":"23","author":"Palmer","year":"2017","journal-title":"Mol Hum Reprod"},{"key":"B387","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"B388","doi-asserted-by":"publisher","DOI":"10.1007\/s40292-023-00608-y","article-title":"First trimester CD93 as a novel marker of preeclampsia and its complications: A pilot study","volume":"30","author":"Piani","year":"2023","journal-title":"High Blood Pressure Cardiovasc Prev"},{"key":"B389","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910549","article-title":"Low levels of complement factor H in the first trimester of pregnancy are associated with spontaneous preterm birth","volume":"25","author":"Becerra-Mojica","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B390","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17529","article-title":"Identification of complement factor H variants that predispose to pre-eclampsia: A genetic and functional study","volume":"130","author":"Lokki","year":"2023","journal-title":"Bjog"},{"key":"B391","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013148","article-title":"Cohort profile: the finnish genetics of pre-eclampsia consortium (FINNPEC)","volume":"6","author":"J\u00e4\u00e4skel\u00e4inen","year":"2016","journal-title":"BMJ Open"},{"key":"B392","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.842451","article-title":"Circulating levels of anti-C1q and anti-factor H autoantibodies and their targets in normal pregnancy and preeclampsia","volume":"13","author":"Dijkstra","year":"2022","journal-title":"Front Immunol"},{"key":"B393","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1351898","article-title":"Protective role of complement factor H against the development of preeclampsia","volume":"15","author":"Yasmin","year":"2024","journal-title":"Front Immunol"},{"key":"B394","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med"},{"key":"B395","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1419540","article-title":"Systematic review of the complement components as potential biomarkers of pre-eclampsia: pitfalls and opportunities","volume":"15","author":"Balduit","year":"2024","journal-title":"Front Immunol"},{"key":"B396","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16660","article-title":"Dysfunction of complement receptors CR3 (CD11b\/18) and CR4 (CD11c\/18) in pre-eclampsia: a genetic and functional study","volume":"128","author":"Lokki","year":"2021","journal-title":"Bjog"},{"key":"B397","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/1471-0528.16664","article-title":"Complement receptors in pre-eclampsia: cleaning up placental debris","volume":"128","author":"Burwick","year":"2021","journal-title":"Bjog"},{"key":"B398","doi-asserted-by":"publisher","DOI":"10.1038\/s41435-024-00310-6","article-title":"Understanding rare genetic variants within the terminal pathway of complement system in preeclampsia","volume":"26","author":"Lokki","year":"2025","journal-title":"Genes Immun"},{"key":"B399","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13092","article-title":"Lectin pathway proteins of the complement system in normotensive pregnancy and pre-eclampsia","volume":"81","author":"Larsen","year":"2019","journal-title":"Am J Reprod Immunol"},{"key":"B400","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1365-2249.2012.04590.x","article-title":"Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia","volume":"169","author":"Halmos","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"B401","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gam003","article-title":"Mannose-binding lectin (MBL) codon 54 gene polymorphism protects against development of pre-eclampsia, HELLP syndrome and pre-eclampsia-associated intrauterine growth restriction","volume":"13","author":"Sziller","year":"2007","journal-title":"Mol Hum Reprod"},{"key":"B402","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2007.10.002","article-title":"Mannose-binding lectin genotypes and pre-eclampsia: a case-control study","volume":"68","author":"van de Geijn","year":"2007","journal-title":"Hum Immunol"},{"key":"B403","doi-asserted-by":"publisher","first-page":"263109","DOI":"10.1155\/2015\/263109","article-title":"Complement split products in amniotic fluid in pregnancies subsequently developing early-onset preeclampsia","volume":"2015","author":"Banadakoppa","year":"2015","journal-title":"Dis Markers"},{"key":"B404","article-title":"Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid","volume":"73","author":"Haeger","year":"1989","journal-title":"Obstet Gynecol"},{"key":"B405","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12349","article-title":"Urinary excretion of C5b-9 is associated with the anti-angiogenic state in severe preeclampsia","volume":"73","author":"Guseh","year":"2015","journal-title":"Am J Reprod Immunol"},{"key":"B406","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01420","article-title":"Urinary excretion of C5b-9 in severe preeclampsia: tipping the balance of complement activation in pregnancy","volume":"62","author":"Burwick","year":"2013","journal-title":"Hypertension"},{"key":"B407","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002980","article-title":"Terminal complement activation in preeclampsia","volume":"132","author":"Burwick","year":"2018","journal-title":"Obstet Gynecol"},{"key":"B408","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.194324","article-title":"Preeclampsia is characterized by placental complement dysregulation","volume":"60","author":"Buurma","year":"2012","journal-title":"Hypertension"},{"key":"B409","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00312","article-title":"Complement activation and regulation in preeclamptic placenta","volume":"5","author":"Lokki","year":"2014","journal-title":"Front Immunol"},{"key":"B410","doi-asserted-by":"publisher","DOI":"10.1080\/10641955.2019.1640725","article-title":"Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia","volume":"38","author":"Yonekura Collier","year":"2019","journal-title":"Hypertens Pregnancy"},{"key":"B411","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.144.8.3099","article-title":"Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy","volume":"144","author":"Holmes","year":"1990","journal-title":"J Immunol"},{"key":"B412","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830220635","article-title":"Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55)","volume":"22","author":"Holmes","year":"1992","journal-title":"Eur J Immunol"},{"key":"B413","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13466","article-title":"Complement 5a-mediated trophoblasts dysfunction is involved in the development of pre-eclampsia","volume":"22","author":"Ma","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B414","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061022","article-title":"Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction","volume":"203","author":"Girardi","year":"2006","journal-title":"J Exp Med"},{"key":"B415","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13033","article-title":"Upregulation and release of soluble fms-like tyrosine kinase receptor 1 mediated by complement activation in human syncytiotrophoblast cells","volume":"80","author":"Banadakoppa","year":"2018","journal-title":"Am J Reprod Immunol"},{"key":"B416","doi-asserted-by":"publisher","first-page":"103322","DOI":"10.1016\/j.jri.2021.103322","article-title":"Complement activation by an angiogenic imbalance leads to systemic vascular endothelial dysfunction: A new proposal for the pathophysiology of preeclampsia","volume":"145","author":"Matsuyama","year":"2021","journal-title":"J Reprod Immunol"},{"key":"B417","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11133611","article-title":"Variation of complement protein levels in maternal plasma and umbilical cord blood during normal pregnancy: an observational study","volume":"11","author":"Saleh","year":"2022","journal-title":"J Clin Med"},{"key":"B418","first-page":"86","article-title":"Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood","volume":"5","author":"Miyano","year":"1987","journal-title":"Diagn Clin Immunol"},{"key":"B419","doi-asserted-by":"publisher","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Holers","year":"2002","journal-title":"J Exp Med"},{"key":"B420","doi-asserted-by":"publisher","DOI":"10.1002\/path.2893","article-title":"Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss","volume":"225","author":"Cohen","year":"2011","journal-title":"J Pathol"},{"key":"B421","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-024-05564-x","article-title":"Pregnancies in patients with systemic lupus erythematosus during 2000\u20132018 in Finland: a case-control study","volume":"44","author":"Elfving","year":"2024","journal-title":"Rheumatol Int"},{"key":"B422","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316664996","article-title":"Systemic lupus erythematosus pregnancies: ten-year data from a single centre in Malaysia","volume":"26","author":"Teh","year":"2017","journal-title":"Lupus"},{"key":"B423","article-title":"Predictors of adverse pregnancy outcome in a cohort of women with systemic lupus erythematosus in Malaysia","volume":"76","author":"Ong","year":"2021","journal-title":"Med J Malaysia"},{"key":"B424","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2011.572310","article-title":"Pregnancy in women with systemic lupus erythematosus: a retrospective study of 111 pregnancies in Chinese women","volume":"25","author":"Liu","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B425","doi-asserted-by":"publisher","DOI":"10.18295\/squmj.2021.21.02.013","article-title":"Pregnancy Outcomes in Systemic Lupus Erythematosus Women: A single tertiary centre experience","volume":"21","author":"Al-Riyami","year":"2021","journal-title":"Sultan Qaboos Univ Med J"},{"key":"B426","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2020-000400","article-title":"Outcomes of pregnancy and associated factors in sub-Saharan African women with systemic lupus erythematosus: a scoping review","volume":"7","author":"Essouma","year":"2020","journal-title":"Lupus Sci Med"},{"key":"B427","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu397oa","article-title":"Activation of complement mediates antiphospholipid antibody-induced pregnancy loss","volume":"12","author":"Salmon","year":"2003","journal-title":"Lupus"},{"key":"B428","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.941586","article-title":"Placental damage in pregnancies with systemic lupus erythematosus: A narrative review","volume":"13","author":"Castellanos Gutierrez","year":"2022","journal-title":"Front Immunol"},{"key":"B429","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e328363ebf7","article-title":"Pathogenesis of pregnancy complications in systemic lupus erythematosus","volume":"25","author":"Ostensen","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"B430","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"key":"B431","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet."},{"key":"B432","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000126245.35811.2a","article-title":"Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"103","author":"Sibai","year":"2004","journal-title":"Obstet Gynecol"},{"key":"B433","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.309.6966.1395","article-title":"Eclampsia in the United Kingdom","volume":"309","author":"Douglas","year":"1994","journal-title":"Bmj"},{"key":"B434","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2016.01.005","article-title":"Direct evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome","volume":"44","author":"Vaught","year":"2016","journal-title":"Exp Hematol"},{"key":"B435","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2020.1755650","article-title":"A review of the alternative pathway of complement and its relation to HELLP syndrome: is it time to consider HELLP syndrome a disease of the alternative pathway","volume":"35","author":"Vaught","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B436","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.11.802","article-title":"HELLP syndrome is characterized by a unique pattern of complement protein biomarkers","volume":"226","author":"Burwick","year":"2022","journal-title":"Am J Obstetrics Gynecology"},{"key":"B437","doi-asserted-by":"publisher","DOI":"10.1080\/10641955.2021.1983593","article-title":"Dysregulation of complement system in HELLP syndrome","volume":"40","author":"Chen","year":"2021","journal-title":"Hypertension Pregnancy"},{"key":"B438","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148162","article-title":"Complement activation drives progression of pre-eclampsia to HELLP syndrome","volume":"138","author":"Shah","year":"2021","journal-title":"Blood"},{"key":"B439","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99128","article-title":"Germline mutations in the alternative pathway of complement predispose to HELLP syndrome","volume":"3","author":"Vaught","year":"2018","journal-title":"JCI Insight"},{"key":"B440","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014746","article-title":"Complement C5 Inhibition in early onset HELLP Syndrome","volume":"9","author":"Gerber","year":"2025","journal-title":"Blood Adv"},{"key":"B441","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/16.1.102","article-title":"Obstetric and neonatal outcome in women with a history of recurrent miscarriage: a cohort study","volume":"16","author":"Jivraj","year":"2001","journal-title":"Hum Reprod"},{"key":"B442","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(03)00321-2","article-title":"Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway","volume":"19","author":"Mao","year":"2003","journal-title":"Immunity"},{"key":"B443","doi-asserted-by":"publisher","DOI":"10.31083\/j.ceog5011252","article-title":"Expression and correlation of complement C3 and C4 in serum and maternal-fetal interface in patients with unexplained recurrent spontaneous abortion: A prospective cohort study","volume":"50","author":"Zhou","year":"2023","journal-title":"CEOG"},{"key":"B444","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del229","article-title":"Complement as a predictor of further miscarriage in couples with recurrent miscarriages","volume":"21","author":"Sugiura-Ogasawara","year":"2006","journal-title":"Hum Reprod"},{"key":"B445","doi-asserted-by":"publisher","first-page":"104221","DOI":"10.1016\/j.jri.2024.104221","article-title":"Angiogenic factors and the lectin pathway of complement in women with secondary recurrent pregnancy loss","volume":"163","author":"Krog","year":"2024","journal-title":"J Reprod Immunol"},{"key":"B446","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201243196","article-title":"Analysis of genes coding for CD46, CD55, and C4b-binding protein in patients with idiopathic, recurrent, spontaneous pregnancy loss","volume":"43","author":"Mohlin","year":"2013","journal-title":"Eur J Immunol"},{"key":"B447","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01813","article-title":"Analysis of C3 gene variants in patients with idiopathic recurrent spontaneous pregnancy loss","volume":"9","author":"Mohlin","year":"2018","journal-title":"Front Immunol"},{"key":"B448","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/cen.14322","article-title":"Complement activation in polycystic ovary syndrome occurs in the postprandial and fasted state and is influenced by obesity and insulin sensitivity","volume":"94","author":"Lewis","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B449","doi-asserted-by":"publisher","DOI":"10.3390\/cells12152002","article-title":"Complement dysregulation in obese versus nonobese polycystic ovary syndrome patients","volume":"12","author":"Butler","year":"2023","journal-title":"Cells"},{"key":"B450","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.935750","article-title":"Classical and alternate complement factor overexpression in non-obese weight matched women with polycystic ovary syndrome does not correlate with vitamin D","volume":"13","author":"Moin","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B451","doi-asserted-by":"publisher","DOI":"10.1097\/01.EDE.0000059921.71494.D1","article-title":"Maternal body mass index and the risk of preeclampsia: a systematic overview","volume":"14","author":"O\u2019Brien","year":"2003","journal-title":"Epidemiology"},{"key":"B452","doi-asserted-by":"publisher","DOI":"10.1080\/13557858.2017.1315367","article-title":"Higher prepregnancy body mass index is a risk factor for developing preeclampsia in Maya-Mestizo women: a cohort study","volume":"23","author":"Canto-Cetina","year":"2018","journal-title":"Ethn Health"},{"key":"B453","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s12884-014-0422-y","article-title":"Pre-pregnancy Body Mass Index (BMI) and delivery outcomes in a Canadian population","volume":"14","author":"Vinturache","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"B454","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-024-01299-z","article-title":"The role of obesity in the development of preeclampsia","volume":"26","author":"Schiavone","year":"2024","journal-title":"Curr Hypertens Rep"},{"key":"B455","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4239\/wjd.v11.i1.1","article-title":"Complement activation in obesity, insulin resistance, and type 2 diabetes mellitus","volume":"11","author":"Shim","year":"2020","journal-title":"World J Diabetes"},{"key":"B456","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0323","article-title":"The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation","volume":"58","author":"Mamane","year":"2009","journal-title":"Diabetes"},{"key":"B457","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300038","article-title":"The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance","volume":"191","author":"Phieler","year":"2013","journal-title":"J Immunol"},{"key":"B458","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2012.02.035","article-title":"Prepregnancy obesity and complement system activation in early pregnancy and the subsequent development of preeclampsia","volume":"206","author":"Lynch","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"B459","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00102.2018","article-title":"Obesity \u201ccomplements\u201d preeclampsia","volume":"51","author":"Olson","year":"2019","journal-title":"Physiol Genomics"},{"key":"B460","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2012.02.023","article-title":"Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis","volume":"62","author":"Robinson","year":"2012","journal-title":"Horm Behav"},{"key":"B461","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.575197","article-title":"Maternal immunological adaptation during normal pregnancy","volume":"11","author":"Abu-Raya","year":"2020","journal-title":"Front Immunol"},{"key":"B462","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2017.06.016","article-title":"An examination of changes in maternal neuroimmune function during pregnancy and the postpartum period","volume":"66","author":"Sherer","year":"2017","journal-title":"Brain Behavior Immun"},{"key":"B463","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2015.08.003","article-title":"Neuroactive steroids and stress axis regulation: Pregnancy and beyond","volume":"160","author":"Brunton","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B464","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413337","article-title":"Immune and metabolic mechanisms of endothelial dysfunction","volume":"25","author":"Kopaliani","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B465","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1161\/HYPERTENSIONAHA.121.17955","article-title":"Immune system and microvascular remodeling in humans","volume":"79","author":"Rizzoni","year":"2022","journal-title":"Hypertension"},{"key":"B466","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12958-021-00742-z","article-title":"Serum complement proteomics reveal biomarkers for hypertension disorder of pregnancy and the potential role of Clusterin","volume":"19","author":"Zeng","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"B467","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2021.10.064","article-title":"Role of clusterin in the regulation of trophoblast development and preeclampsia","volume":"583","author":"Zeng","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B468","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200300565","article-title":"Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia","volume":"4","author":"Watanabe","year":"2004","journal-title":"PROTEOMICS"},{"key":"B469","doi-asserted-by":"publisher","DOI":"10.1515\/jpm-2015-0120","article-title":"Increased levels of serum clusterin is associated with intrauterine growth restriction and adverse pregnancy outcomes in preeclampsia","volume":"44","author":"Oztas","year":"2016","journal-title":"J Perinatal Med"},{"key":"B470","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1186\/s12864-024-10827-9","article-title":"Clusterin from endometrial glands plays a critical role in decidualization via Trem2","volume":"25","author":"Yao","year":"2024","journal-title":"BMC Genomics"},{"key":"B471","doi-asserted-by":"publisher","first-page":"104692","DOI":"10.1016\/j.mvr.2024.104692","article-title":"Endothelial dysfunction and complement activation are independently associated with disease duration in patients with systemic vasculitis","volume":"154","author":"Dolgyras","year":"2024","journal-title":"Microvasc Res"},{"key":"B472","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2016_90","article-title":"Endothelial dysfunction and hypertension","volume":"956","author":"Konukoglu","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B473","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-023-01300-3","article-title":"Endothelial-derived complement factor D contributes to endothelial dysfunction in Malignant nephrosclerosis via local complement activation","volume":"46","author":"Wang","year":"2023","journal-title":"Hypertension Res"},{"key":"B474","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg7942","article-title":"Persistent complement dysregulation with signs of thromboinflammation in active Long Covid","volume":"383","author":"Cervia-Hasler","year":"2024","journal-title":"Science"},{"key":"B475","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.medj.2024.01.011","article-title":"Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID","volume":"5","author":"Baillie","year":"2024","journal-title":"Med"},{"key":"B476","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15171","article-title":"The role of complement in arterial hypertension and hypertensive end organ damage","volume":"178","author":"Wenzel","year":"2021","journal-title":"Br J Pharmacol"},{"key":"B477","doi-asserted-by":"publisher","DOI":"10.2741\/314","article-title":"Endothelial damage\/dysfunction and hypertension in pregnancy","volume":"3","author":"Karthikeyan","year":"2011","journal-title":"Front Biosci (Elite Ed)"},{"key":"B478","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.15072","article-title":"Endothelial damage and complement dysregulation in fetuses from pregnancies complicated by preeclampsia","volume":"104","author":"Ramos","year":"2025","journal-title":"Acta Obstetricia Gynecologica Scandinavica"},{"key":"B479","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-019-0371-y","article-title":"Role of complement 3 in the pathogenesis of hypertension","volume":"43","author":"Chen","year":"2020","journal-title":"Hypertension Res"},{"key":"B480","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.05484","article-title":"Classical complement pathway activation in the kidneys of women with preeclampsia","volume":"66","author":"Penning","year":"2015","journal-title":"Hypertension"},{"key":"B481","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cca.2010.09.030","article-title":"Pre-eclampsia: Relationship between coagulation, fibrinolysis and inflammation","volume":"412","author":"Dusse","year":"2011","journal-title":"Clinica Chimica Acta"},{"key":"B482","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1182\/blood.V122.21.3525.3525","article-title":"Pregnancies complicated by severe preeclampsia exhibit perturbed von willebrand factor (VWF)-associated parameters","volume":"122","author":"Drury-Stewart","year":"2013","journal-title":"Blood"},{"key":"B483","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12959-025-00727-7","article-title":"Von Willebrand disease (VWD) and pregnancy: a comprehensive overview","volume":"23","author":"Soleimani Samarkhazan","year":"2025","journal-title":"Thromb J"},{"key":"B484","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/00006254-197206000-00001","article-title":"Hematologic evidence of disseminated intravascular coagulation in eclampsia","volume":"27","author":"MCKAY","year":"1972","journal-title":"Obstetrical Gynecological Survey"},{"key":"B485","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199706000-00004","article-title":"Acquired deficiency of antithrombin in association with a hypercoagulable state and impaired function of liver and\/or kidney in preeclampsia","volume":"8","author":"He","year":"1997","journal-title":"Blood coagulation fibrinolysis"},{"key":"B486","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.2.361.361","article-title":"Consecutive enzyme cascades: complement activation at the cell surface triggers increased tissue factor activity","volume":"76","author":"Carson","year":"1990","journal-title":"Blood"},{"key":"B487","doi-asserted-by":"publisher","first-page":"152707","DOI":"10.1016\/j.imbio.2023.152707","article-title":"Complement and coagulation crosstalk \u2013 Factor H in the spotlight","volume":"228","author":"Heurich","year":"2023","journal-title":"Immunobiology"},{"key":"B488","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109269","article-title":"C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation","volume":"63","author":"Muhlfelder","year":"1979","journal-title":"J Clin Invest"},{"key":"B489","article-title":"C5a induces tissue factor activity on endothelial cells","volume":"77","author":"Ikeda","year":"1997","journal-title":"Thromb Haemost"},{"key":"B490","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.02.011","article-title":"Complement activation in arterial and venous thrombosis is mediated by plasmin","volume":"5","author":"Foley","year":"2016","journal-title":"EBioMedicine"},{"key":"B491","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular intercommunication between the complement and coagulation systems","volume":"185","author":"Amara","year":"2010","journal-title":"J Immunol"},{"key":"B492","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-78952-1_6","article-title":"Interaction between the coagulation and complement system","volume":"632","author":"Amara","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"B493","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1038\/s41598-021-82733-z","article-title":"Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics","volume":"11","author":"Youssef","year":"2021","journal-title":"Sci Rep"},{"key":"B494","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2025.03.009","article-title":"Assessment of complement cascade components in patients with major depressive disorder","volume":"127","author":"Quintanilla","year":"2025","journal-title":"Brain Behavior Immun"},{"key":"B495","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14734","article-title":"Identification of depression and anxiety during pregnancy: A systematic review and meta-analysis of test accuracy","volume":"103","author":"Rondung","year":"2024","journal-title":"Acta Obstetricia Gynecologica Scandinavica"},{"key":"B496","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/e439372005-001","article-title":"Perinatal depression: prevalence, screening accuracy, and screening outcomes","volume":"2005","author":"Gaynes","year":"","journal-title":"Evid Rep Technol Assess (Summ)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1617140\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T05:19:48Z","timestamp":1755580788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1617140\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":496,"alternative-id":["10.3389\/fimmu.2025.1617140"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1617140","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"article-number":"1617140"}}